Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.

Journal of virological methods - 1 Mar 2017

Wallis Carole L, Viana Raquel V, Saravanan Shanmugam, Silva de Jesus Carlos, Zeh Clement, Halvas Elias K, Mellors John W

Abstract excerpt

BACKGROUND: HIV-1 sequence variation is a major obstacle to developing molecular based assays for multiple subtypes. This study sought to independently assess performance characteristics of the ViroSeq™ HIV-1 Integrase RUO Genotyping Kit (Celera, US) for samples of multiple different HIV-1 subtypes. METHODS: 264 samples were tested in the validation, 106 from integrase inhibitor naïve patients' sent for routine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to Genotyping Techniques

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Integrase

Share to HIV Integrase Inhibitors

Share to Reproducibility of Results

Share to RNA, Viral

Source

Open in PubMed Open full text

Identifiers

PMID: 27993614
DOI: 10.1016/j.jviromet.2016.12.008
PMCID: PMC5292360

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.PMID 27993614Read ↗

Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains.Semantic proximity Read ↗

An HIV-1 integrase genotype assay for the detection of drug resistance mutations.Semantic proximity Read ↗

Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System.Semantic proximity Read ↗

Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing.Semantic proximity Read ↗

Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase.Semantic proximity Read ↗

Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer.Semantic proximity Read ↗

Accuracy of the TRUGENE HIV-1 genotyping kit.Semantic proximity Read ↗

Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.Semantic proximity Read ↗

Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples.Semantic proximity Read ↗

HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitroSemantic proximity Read ↗

Development and Optimization of Oligonucleotide Ligation Assay (OLA) Probes for Detection of HIV-1 Resistance to Dolutegravir.Semantic proximity Read ↗

Analysis of HIV type 1 gp41 sequences in diverse HIV type 1 strains.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.